Business Wire

SOSLAB’s LiDAR ‘ML’ for Automotive Wins CES Innovation Award

Share

SOSLAB that specializes in LiDAR, won the CES 2021 Innovation Awards at the world's largest electronics exhibition 'CES 2021,' for its Solid-state LiDAR ‘ML’ for automotive.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210112005486/en/

Professional LiDAR Sensor provider SOSLAB won the CES 2021 Innovation Awards for its Solid-state LiDAR ML for automotive. The Solid-state LiDAR ML for autonomous vehicles won the Innovation Awards in the Vehicle Intelligence and Transportation category. This award recognizes the excellence of this product ML: Compact LiDAR without moving parts inside which enables simpler vehicle sensor deployment in terms of size, weight and stability. ML is easy to mass-produce with a simple structural design which is expected to attract attention in the automotive LiDAR market. ML will be supplied to strategic partners only, launching prototype products in the global market at CES 2021. More information on ML can be found at the SOSLAB booth at the CES 2021 exhibition held online from January 11th to 14th. (Photo: Business Wire)

Professional LiDAR Sensor provider SOSLAB won the CES 2021 Innovation Awards for its Solid-state LiDAR ML for automotive. The Solid-state LiDAR ML for autonomous vehicles won the Innovation Awards in the Vehicle Intelligence and Transportation category. This award recognizes the excellence of this product ML: Compact LiDAR without moving parts inside which enables simpler vehicle sensor deployment in terms of size, weight and stability. ML is easy to mass-produce with a simple structural design which is expected to attract attention in the automotive LiDAR market. ML will be supplied to strategic partners only, launching prototype products in the global market at CES 2021. More information on ML can be found at the SOSLAB booth at the CES 2021 exhibition held online from January 11th to 14th. (Photo: Business Wire)

The CES Innovation Awards are awarded by about 50 expert judges who select the most innovative products in 28 categories each year. The products selected for this innovation award are displayed at the CES Innovation Showcase from January 11th.

SOSLAB’s Solid-state LiDAR ‘ML’ for autonomous vehicles won the Innovation Awards in the Vehicle Intelligence & Transportation category. This award recognizes the excellence of this product ML: Compact LiDAR without moving parts inside which enables simpler vehicle sensor deployment in terms of size, weight and stability.

The mechanical type of LiDAR currently used for research on autonomous driving has a limitation in mass production due to the system complexity caused by the moving components; ML is easy to mass-produce with a simple structural design which is expected to attract attention in the automotive LiDAR market.

ML was previously unveiled at KES2020 held at the COEX Exhibition Hall last year and will be supplied to strategic partners only, launching prototype products in the global market at CES 2021. More information on ML can be found at the SOSLAB booth at the CES 2021 exhibition held online from January 11th to 14th.

SOSLAB’s CEO, Jiseong Jeong said, “SOSLAB will become a company that makes the world smarter with LiDAR. Along with the verification of ML's technical excellence, we plan to complete product performance verification and auto-grade qualification by the second half of this year by securing additional capital with the goal of mass production of Solid-state LiDARs in 2022. SOSLAB will grow into a company that leads the global LiDAR market by commercializing LiDAR for vehicles.”

See SOSLAB's Compact 3D Solid-state LiDAR ‘ML’ video on
https://youtu.be/o3hSOnNKlDw

Additional Info.
Website: http://soslab.co/
YouTube: https://www.youtube.com/soslab

About SOSLAB
SOSLAB specializes in LiDAR (Light Detection and Ranging), which measures the distance to an object using light. We develop and supply 2D and 3D LiDARs to the market, growing into a global company by successfully developing Solid-state LiDAR for automotive.

Contact information

SOSLAB
Ellie Yeojin Kim / Marketing Manager
+82-62-973-5051
ellie.kim@soslab.co

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Velodyne Lidar Signs Multi-Year Sales Agreement with Emesent26.1.2021 13:00:00 CETPress release

Velodyne Lidar, Inc. (Nasdaq: VLDR, VLDRW) today announced a multi-year sales agreement to provide Puck LITE™ sensors to Emesent, a world-leader in drone autonomy, lidar mapping and data analytics. Emesent is using Velodyne’s lidar sensors to power its award-winning Hovermap mobile scanning system for mapping hazardous and GPS-denied environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210126005229/en/ Emesent’s Hovermap, equipped with a Velodyne Puck LITE™ sensor, has a colorization feature for its 3D point clouds that brings additional context for visualization and analysis. (Photo: Emesent) Hovermap, which can be hand-held or mounted to a drone, uses Puck LITE lidar as its primary perception and mapping sensor. Equally capable above ground or underground, indoors or out, Hovermap combines advanced collision avoidance and autonomous flight technologies to map challenging, inaccessible areas. Hovermap has a coloriza

Allurion Technologies Launches Virtual Care Suite to Transform the Consumer and Provider Experience26.1.2021 13:00:00 CETPress release

https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fallurion.com%2F&esheet=52366910&newsitemid=20210126005074&lan=en-US&anchor=Allurion%26%23174%3B+Technologies&index=1&md5=a32a2cae6846c1f555e8ab3892c63eae Allurion® Technologies, a pioneering leader in the development of innovative, scalable and trusted weight loss experiences, today announced a major milestone for its AllurionTM Weight Loss Program with the launch of its new digital health offering featuring the Allurion TM Health Tracker smartwatch, Allurion® Connected Scale, Allurion® mobile app, and the Allurion TM Clinic Dashboard, the first in a series of new provider services that make up the Allurion TM Virtual Care Suite. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210126005074/en/ The Allurion Connected Scale and Health Tracker measure all aspects of body composition including weight, body fat, muscle mass, as well as activity data such as steps, ex

Takeda Achieves Industry-Leading Positions in 2021 Access to Medicine Index26.1.2021 12:35:00 CETPress release

Takeda Pharmaceutical Company Limited(TSE:4502/NYSE:TAK) (“Takeda”) has earned an industry-leading position within the 2021 Access to Medicine (AtM) Index published today. Specifically the company achieved notable, high scores in all three technical areas evaluated by the Index, including being ranked first in Governance of Access. Takeda also demonstrated strong performance in the areas of health system strengthening, compliance and R&D capacity building, according to the Index. “This honor underscores Takeda’s commitment to prioritizing patient needs by ensuring access to our life-transforming treatments,” said Christophe Weber, Takeda president and chief executive officer. “As a purpose-driven company that puts the patient at the center of everything we do, we are committed to not just inventing medicines but making sure patients can access transformative therapies.” The AtM Index is a rigorous, biennial research project combining data-collection, verification, scoring and analysis

IFF Announces Preliminary Fourth Quarter & Full Year 2020 Financial Results26.1.2021 12:35:00 CETPress release

IFF (NYSE:IFF), a leading innovator of taste, scent, and nutrition & ingredients, today announced preliminary, unaudited financial results for the quarter ended December 31, 2020. “In collaboration with DuPont’s financial announcement today, and in connection with the Exchange Offer related to our combination with DuPont Nutrition & Biosciences, we are providing preliminary financial results for the fourth quarter and full year 2020,” said IFF Chairman and CEO Andreas Fibig. “We expect to finish 2020 with results coming in ahead of our expectations despite continued challenges and complexity of the pandemic. This performance is a direct testament to the diversity of our portfolio, the essential nature of our products, and the resiliency of our global teams to continuously deliver for our customers.” Mr. Fibig continued, “With the completion of our merger with DuPont N&B now just days away, we continue to see multiple paths to strong value creation for all our stakeholders. Upon closing

Tilray® Selected by French National Agency to Supply GMP-Certified Medical Cannabis Products in France26.1.2021 12:00:00 CETPress release

Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis production, research, cultivation, and distribution, announced that it has been selected by the French National Agency for the Safety of Medicines and Health Products (ANSM) to supply Good Manufacturing Processes (GMP) certified medical cannabis products for experimentation in France. Tilray will supply GMP-produced medical cannabis products to serve patients in need for the duration of the French experiment (18-24 months), due to begin in the first quarter of 2021. Tilray products will be administered to qualifying patients in the French experiment, for whom existing treatments do not provide sufficient relief from their symptoms, and for therapeutic indications including: Neuropathic pain that is refractory to therapies currently available (drug or non-drug treatments); Certain forms of epilepsy that are drug-resistant; In certain persistent symptoms in oncology, related to cancer or anti-cancer treatment; In palliative care s

Aqua Lung Welcomes World-Renowned Wildlife Photographer and Conservationist Paul Nicklen as a Global Ocean Ambassador26.1.2021 12:00:00 CETPress release

Aqua Lung, the celebrated pioneer, designer, manufacturer and distributor of dive and watersports equipment for 75 years, today announced world-renowned wildlife photographer and conservationist Paul Nicklen is joining the brand as a global ocean ambassador. As part of the partnership, Nicklen will exclusively use Aqua Lung, Apeks, and O.ME.R. products during all dive expeditions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210126005122/en/ Aqua Lung global ocean ambassador and SeaLegacy co-founder, Paul Nicklen with co-founder and President of SeaLegacy, Cristina Mittermeier. Photo credit: Joe Leahy Nicklen, best-known for his incomparable underwater photography and ocean conservation efforts, will utilize the full range of industry-leading Aqua Lung, Apeks and O.ME.R. products from wetsuits, masks and fins to technical gear and regulators. Helping to grow the brand globally, Nicklen joins an elite roster of ambassadors

New Study Concludes Xlear Kills and/or Deactivates SARS-CoV-2; Efficacy Against New Variants26.1.2021 10:15:00 CETPress release

A new in vitro study done collaboratively by Utah State University and Northwestern University finds Xlear components (grapefruit seed extract and xylitol) significantly eliminates SARS-CoV-2, the virus that causes COVID-19. The imaging research study component was performed at the BioCryo facility of Northwestern University’s NUANCE Center. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210126005436/en/ Using electron microscopy, we have visual evidence showing that xylitol and grapefruit seed extract (GSE) counters the virus. The GSE kills the virus, while the xylitol prevents the virus from attaching to the cell walls. The image shows SARS-CoV-2 viruses outside the cell and never attached, thereby preventing infection (Photo: Business Wire) The study tested SARS-CoV-2 virus titers and LRV against a single concentration of Xlear nasal spray. According to the Study, “After a 25-minute contact time, the nasal spray reduced v